Search Ontology:
ChEBI

midafotel

Term ID
CHEBI:180900
Synonyms
  • (2R)-4-[(2E)-3-phosphono-2-propenyl]-2-piperazinecarboxylic acid
  • (2R)-4-[(2E)-3-phosphonoprop-2-en-1-yl]piperazine-2-carboxylic acid
  • (R)-4-[(E)-3-phosphonoprop-2-enyl]piperazine-2-carboxylic acid
  • (R)-CPP-ene
  • D(-)CPPene
  • D-4-[(2E)-3-phosphono-2-propenyl]-2-piperazinecarboxylic acid
  • D-CPP-ene
  • D-CPPene
  • midafotel
  • midafotelum
  • SDZ EAA 494
  • SDZ-EAA 494
  • SDZ-EAA-494
Definition
A member of the class of piperazines that is piperazine substituted by a carboxy group at position 2R and a (1E)-1-phosphonoprop-1-en-3-yl group at position 4. It is an antagonist of N-methyl-D-aspartate receptors (NMDARs) and was in clinical development by Novartis for the treatment of cognition disorders and brain injuries (now discontinued).
References
  • cas:117414-74-1
  • chemspider:4940497
  • pubmed:10422758
  • pubmed:10708738
  • pubmed:11396518
  • pubmed:1480321
  • pubmed:15497436
  • pubmed:1834008
  • pubmed:1930876
  • pubmed:2147454
  • pubmed:2166255
  • pubmed:2166743
  • pubmed:2292244
  • pubmed:31563294
  • pubmed:32507787
  • pubmed:7675315
  • pubmed:7892415
  • pubmed:7894335
  • pubmed:7936096
  • pubmed:7942207
  • pubmed:7976650
  • pubmed:8194512
  • pubmed:8223415
  • pubmed:8269915
  • pubmed:8581475
  • pubmed:8740048
  • pubmed:8901001
  • pubmed:8982681
  • pubmed:9026366
  • pubmed:9721021
  • pubmed:9726648
  • wikipedia.en:Midafotel
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from midafotel
Phenotype where environments contain midafotel
Phenotype modified by environments containing midafotel
Phenotype affecting midafotel
Human Disease Model